ID   4H6.17.8
AC   CVCL_B0EE
SY   4H6
DR   ATCC; HB-12455
DR   Wikidata; Q108819669
RX   Patent=US7744881;
RX   Patent=US20110002933;
RX   Patent=WO1999037684A1;
RX   PubMed=11290766;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12455.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O00220; Human TNFRSF10A/CD261.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=US7744881;
RA   Chuntharapai A., Kim K.J.;
RT   "Human DR4 antibodies and uses thereof.";
RL   Patent number US7744881, 29-Jun-2010.
//
RX   Patent=US20110002933;
RA   Ashkenazi A.J., Chuntharapai A., Dodge K.H., Kim K.J.;
RT   "DR4 antibodies and uses thereof.";
RL   Patent number US20110002933, 06-Jan-2011.
//
RX   Patent=WO1999037684A1;
RA   Chuntharapai A., Kim K.J.;
RT   "Antibodies to death receptor 4 (DR4) and uses thereof.";
RL   Patent number WO1999037684A1, 29-Jul-1999.
//
RX   PubMed=11290766; DOI=10.4049/jimmunol.166.8.4891;
RA   Chuntharapai A., Dodge K.H., Grimmer K., Schroeder K., Marsters S.A.,
RA   Koeppen H., Ashkenazi A.J., Kim K.J.;
RT   "Isotype-dependent inhibition of tumor growth in vivo by monoclonal
RT   antibodies to death receptor 4.";
RL   J. Immunol. 166:4891-4898(2001).
//